Notably, HLA-I– cancer cells acquiring a mesenchymal status were associated with enhanced mRNA levels of the IFN-stimulated genes IFIT1, IFIT2, IFIT3, IFI6, IFI27, and CCL2. This evidence concerns the gene IFI6 and cancer.